1 research outputs found
10-Iodo-11<i>H</i>‑indolo[3,2‑<i>c</i>]quinoline-6-carboxylic Acids Are Selective Inhibitors of DYRK1A
The protein kinase DYRK1A has been
suggested to act as one of the
intracellular regulators contributing to neurological alterations
found in individuals with Down syndrome. For an assessment of the
role of DYRK1A, selective synthetic inhibitors are valuable pharmacological
tools. However, the DYRK1A inhibitors described in the literature
so far either are not sufficiently selective or have not been tested
against closely related kinases from the DYRK and the CLK protein
kinase families. The aim of this study was the identification of DYRK1A
inhibitors exhibiting selectivity versus the structurally and functionally
closely related DYRK and CLK isoforms. Structure modification of the
screening hit 11<i>H</i>-indoloÂ[3,2-<i>c</i>]Âquinoline-6-carboxylic
acid revealed structure–activity relationships for kinase inhibition
and enabled the design of 10-iodo-substituted derivatives as very
potent DYRK1A inhibitors with considerable selectivity against CLKs.
X-ray structure determination of three 11<i>H</i>-indoloÂ[3,2-<i>c</i>]Âquinoline-6-carboxylic acids cocrystallized with DYRK1A
confirmed the predicted binding mode within the ATP binding site